Retatrutide Study Targets Obesity Without Diabetes Over 113 Weeks | Retatrutide News

A study is evaluating retatrutide's safety and efficacy in people with obesity but without type 2 diabetes. This trial is crucial for understanding reta...
Clinical Trials · October 28, 2026